Patient P-02484

Synthetic patientMETA-24 · Day 178 · 75+ · F · baseline S15Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Favorable

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Declining

Discontinuation risk

29%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S15
Day 17 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 22 GI-04 recommended — GI Support Protocol GI-04
Day 23 Patient accepted — Started GI-04 in the companion
Day 31 GI symptom burden −15% vs expected — GI Support Protocol GI-04
Day 37 Tolerance state changed — Unstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 17.

Primary contributors, last 14 days

Nutritional resilience-10
GI instability+8

What helped?

GI Support Protocol GI-04Day 22
Result: symptom burden −15%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

58 min

worsening · -3.2 vs previous 14 d

Sleep duration

Wearable

6.7 h

stable · +0.1 vs previous 14 d

Energy level

Daily log

5.4/10

stable · +0.0 vs previous 14 d

Steps

Wearable

5,913

stable · -215 vs previous 14 d

GI burden

Companion

28.8/100

worsening · +1.7 vs previous 14 d

Adherence

Companion

94.9 %

stable · -1.1 vs previous 14 d

Sleep quality

Wearable

42/100

improving · +2.1 vs previous 14 d

Glucose, CGM daily mean

CGM

139 mg/dL

stable · -2.5 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 62 from the failing basin, 32 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -6.1 next day on high-intake days · n 21

Would not help

Keep histamine low
GI +6.6 next day on high-intake days · n 22
Keep fat low
GI +6.4 next day on high-intake days · n 18
Keep simple carbs low
GI +5.1 next day on high-intake days · n 21

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
+6.6detractor · 95%
Dietary fat load
+6.4detractor · 95%
Protein
-6.1supporter · 95%
Simple carbohydrates
+5.1detractor · 95%
Ultra-processed food
+2.3no signal · 45%
Caffeine
-1.6no signal · 30%
Alcohol
+1.4no signal · 22%
Insoluble fibre
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓60
- MicrobiomeButyrate capacity 26/100
- MicrobiomeF. prausnitzii depleted
Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
Autonomic recovery ↓25
- WearableResting HR 73 bpm

DNA

Fictional pharmacogenomic panel

FUT2 rs601338 AA (non-secretor)
Reduced mucosal fucosylation
CYP2D6 Rapid metabolizer
Expected exposure

Microbiome

Shannon diversity 2.2 · butyrate capacity 26/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 61 ms
Sleep: 6.8 h
Steps: 5,337
Resting HR: 74 bpm

Daily log: GI score 29, nutritional resilience 54, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02093	37%	S05	AD-05	no change	40
P-02285	36%	S14	AD-05	no change	39
P-02031	35%	S12	AD-05	improved	47
P-02087	39%	S01	BR-03	no change	40
P-02522	39%	S01	BR-03	no change	40
P-02483	37%	S06	BR-03	no change	64
P-02267	33%	S09	BR-03	no change	45
P-02308	33%	S13	BR-03	no change	27
P-02564	33%	S15	BR-03	improved	32
P-02280	32%	S07	BR-03	no change	50
P-02274	52%	S15	DT-01	improved	50
P-02235	46%	S14	DT-01	improved	50